Knight Therapeutics, Inc.

Knight Therapeutics, Inc.

8.25
USD
-0.10
(-1.20%)
0.11EPS
65.52P/E
733.79MMarket Cap
Mar 25Next Earn

Knight Therapeutics, Inc. Documents

Q3 FY2025 · Earnings release

November 6, 2025 · 15 pages

Read Knight Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents